HPV and high-risk gene expression profiles predict response to chemoradiotherapy in head and neck cancer, independent of clinical factors

2010/03/25 by Monique C. de Jong, Jimmy Pramana, Joost L. Knegjens +9 · 1 citation
Medicine · #Biology #Cancer #Chemoradiotherapy #Confidence interval #Hazard ratio #Head and Neck Cancer Studies #Head and neck cancer #Internal medicine #Medicine #Oncology #Oral health in cancer treatment #Pharynx #Salivary Gland Disorders and Functions #Stage (stratigraphy) #Surgery

paper · doi:10.1016/j.radonc.2010.02.001

openalex publication_date 2010/03/25 · crossref created 2010/03/25 · crossref issued 2010/06/01 · crossref published 2010/06/01 · crossref published-print 2010/06/01 · openalex created_date 2016/06/24 · crossref deposited 2019/05/27 · crossref indexed 2025/10/27 · openalex updated_date 2026/08/01

Citations

• Genetic Signatures of HPV-related and Unrelated Oropharyngeal Carcinoma and Their Prognostic Implications
• Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial
• Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): An Update
• Global Cancer Statistics, 2002
• Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta‐analysis

Cited by

• HPV-positive oropharyngeal cancer [wikipedia]